About Adialante
Adialante develops low-cost, clinical-grade MRI systems and related services for accessible cancer and neuroimaging screening.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Pre-Seed
Global Headquarters
San Francisco, United States
Team Size
4 employees
Tracked Since
Sep 28, 2026
Web & Domain Identity
Official Website
adialante.com
Domain Registered Date
Nov 23, 2022
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Pre-Seed announced
- Milestone
Website domain registered
adialante.com
Investors & Backers
Y Combinator
Funding History
Pre-Seed
· Jun 16, 2026
Undisclosed
Venture Round
· Undisclosed
$500,000 Source
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026